SecBot SecBot
6-K ·Filed May 18, 2026

IINNW

Inspira Technologies OXY B.H.N. Ltd
BULLISH
Impact 6/10
Horizondays Processed6mo ago SEC0001185185-26-001890
Notable filing: 6-K
Actionable Insight ▲ Bullish

The $580,000 purchase order from a order from a top-tier academic medical center provides a key commercial reference, supporting Inspira's ongoing strategic process. Traders should watch for potential partnership, licensing, or monetization announcements related to the ART100 platform, which could unlock further value. With a market cap of only $2M, this order represents meaningful revenue relative to scale.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$0.0830
T+0 close · May 18, 2026 · via day close
Latest settled
+57.83%
T+20 · $0.1310
Vs SPY
+56.25%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · May 18 $0.0830entry
  2. T+1 · 6mo ago +71.08%α +71.73% · $0.1420
  3. T+5 · 6mo ago +213.25%α +211.63% · $0.2600
  4. T+20 · 5mo ago +57.83%α +56.25% · $0.1310
  5. T+60 · due 3mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems, blood circulation systems. The order follows a multi-patient clinical evaluation at NYU Langone and is scheduled for immediate fulfillment.

Key Facts

  • Inspira received a $580,000 purchase order from NYU Langone Hospital for the ART100 system.
  • The order was placed through Inspira received follows a multi-patient clinical evaluation involving more than 30 patients.
  • The ART100 system is FDA-cleared for cardiopulmonary bypass procedures.
  • The systems are scheduled for immediate fulfillment.
  • Inspira disclosed it is advancing an 'active strategic process' involving multiple counterparties regarding the ART100 platform and additional medical assets.

Financial Impact

$580,000 commercial purchase order from NYU Langone Hospital.

revenuecommercial adoption

Risk Factors

  • The order is a single, modest transaction that may not extrapolate to scale.
  • The company is actively seeking to monetize ART100 and other medical assets, there is no guarantee of a favorable transaction.
  • No financial details or profitability impact disclosed; historical 20-F shows pre-revenue stage.
  • Warrant ticker IINNW is highly speculative, volatile and prone to large price swings irrespective of news quality.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001185185-26-001890
Document: iinnex99-1.htm0001185185-26-001890
Document: 0001185185-26-001890-index-headers.html0001185185-26-001890
Document: 0001185185-26-001890-index.html0001185185-26-001890
Document: 0001185185-26-001890.txt0001185185-26-001890

Track record

11 reports on IINNW

Performance horizon

1 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +63.33% at T+5 after the Apr 13, 2026 report. 1 of 4 went positive at some point.

Filters
  1. May 19, 202625w ago 6-K Neutral 4/10 Entry $0.1420 to $0.1200 ▼ −15.49% −16.48% vs SPY
  2. May 18, 202626w ago 6-K Bullish 6/10 Viewing Entry $0.0830 to $0.1310 ▲ +57.83% +56.25% vs SPY
  3. Apr 16, 202630w ago 6-K Bullish 7/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  4. Apr 16, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  5. Apr 15, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
  6. Apr 14, 202630w ago 6-K Neutral 3/10 Entry $0.0720 to $0.0690 ▼ −4.17% −10.46% vs SPY
  7. Apr 13, 202631w ago 6-K Bullish 7/10 Entry $0.0600 to $0.0690 ▲ +15.00% +7.27% vs SPY
  8. Apr 6, 202632w ago 6-K Bullish 8/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
  9. Apr 6, 202632w ago 6-K Bullish 7/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
  10. Mar 31, 202632w ago 6-K Neutral 4/10 Entry $0.0800 to $0.0690 ▼ −13.75% −23.17% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026